EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Sinead Delany-Moretlwe iD, Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya, Juliet Mpendo, Muchaneta Bhondai-Mhuri, Nyaradzo Mgodi iD, Rebecca Berhanu, Jennifer Farrior, Estelle Piwowar-Manning und 10 weitere

Journal of the International AIDS Society · 2025-01 · 28 (1)

DOI: 10.1002/jia2.26401 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the International AIDS Society, online erschienen am 02.01.2025. Verfasst von Sinead Delany-Moretlwe und 21 weiteren Autor:innen. Beteiligte Einrichtung: Wits RHI, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, Pyridones. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIMH NIH HHS, ViiV Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long‐acting injectable cabotegravir (CAB‐LA) for pre‐exposure prophylaxis significantly reduced HIV acquisition in HPTN 084. We report on the safety and CAB‐LA pharmacokinetics in pregnant women during the blinded period of HPTN 084.

Methods

Participants were randomized 1:1 to either active cabotegravir (CAB) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) placebo or active TDF/FTC plus CAB placebo. Pregnancy testing was performed at each visit; participants with a positive test had study product withheld and were offered open‐label TDF/FTC. Pregnancies were confirmed on two tests at least 4 weeks apart. All participants with a positive pregnancy test prior to November 5, 2020 are included in this analysis. Pregnancy incidence, maternal adverse event (AE) incidence, pregnancy outcomes (including composite outcome of spontaneous abortion

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsPyridonesHumansFemalePregnancyAdultYoung AdultAfrica, EasternPre-Exposure ProphylaxisAfrica, SouthernPregnancy Complications, InfectiousPregnancy OutcomeTenofovirAdolescentEmtricitabineDiketopiperazines

Stichwörter der Autor:innen

HIV preventionPrEPcabotegravirlong‐actingpregnancywomen

Substanzen

Anti-HIV AgentscabotegravirPyridonesTenofovirEmtricitabineDiketopiperazines

Autor:innen und Institutionen

  • Wits RHI, University of the Witwatersrand, Johannesburg, South Africa.
  • Statistical Centre for HIV/AIDS Research Prevention Fred Hutchinson Cancer Research Institute, Seattle, Washington, USA.
  • Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.
  • University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
  • Baylor College of Medicine Children's Foundation Uganda, Kampala, Uganda.
  • UVRI-IAVI, Entebbe, Uganda.

ORCID-Profile: Sinead Delany-Moretlwe, Nyaradzo Mgodi, Craig W Hendrix, Myron S Cohen, Mina C Hosseinipour

Förderung

  • NIAID NIH HHS
  • NIMH NIH HHS
  • ViiV Healthcare
  • NIDA NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIH HHS
  • Gates Foundation
  • National Institutes of Health

Zitieren

APA

Delany-Moretlwe, S., Hanscom, B., Guo, X., Nkabiito, C., Mandima, P., Nahirya, P. N., Mpendo, J., Bhondai-Mhuri, M., Mgodi, N., Berhanu, R., Farrior, J., Piwowar-Manning, E., Ford, S. L., Hendrix, C. W., Rinehart, A. R., Rooney, J. F., Adeyeye, A., Landovitz, R. J., Cohen, M. S., …, & HPTN 084 Study Team (2025). Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. Journal of the International AIDS Society, 28(1). https://doi.org/10.1002/jia2.26401

Vancouver

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, et al. Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. Journal of the International AIDS Society. 2025;28(1). doi:10.1002/jia2.26401

BibTeX
@article{DelanyMoretlwe2025,
  author = {Delany-Moretlwe, Sinead and Hanscom, Brett and Guo, Xu and Nkabiito, Clemensia and Mandima, Patricia and Nahirya, Patricia Ntege and Mpendo, Juliet and Bhondai-Mhuri, Muchaneta and Mgodi, Nyaradzo and Berhanu, Rebecca and Farrior, Jennifer and Piwowar-Manning, Estelle and Ford, Susan L and Hendrix, Craig W and Rinehart, Alex R and Rooney, James F and Adeyeye, Adeola and Landovitz, Raphael J and Cohen, Myron S and Hosseinipour, Mina C and Marzinke, Mark A and HPTN 084 Study Team, HPTN 084 Study Team},
  title = {Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  volume = {28},
  number = {1},
  doi = {10.1002/jia2.26401}
}
Kostenlos starten →